Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 HKD | +2.22% | -3.50% | -5.48% |
Apr. 03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
Apr. 03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.27B 175M 1.36B |
---|---|---|---|---|---|
Net income 2024 * | -219M -30.28M -236M | Net income 2025 * | -242M -33.46M -261M | EV / Sales 2024 * | - |
Net cash position 2024 * | 2B 277M 2.16B | Net cash position 2025 * | 1.7B 235M 1.83B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.17
x | P/E ratio 2025 * |
-5.5
x | Employees | 219 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 27.46% |
1 day | +2.22% | ||
1 week | -3.50% | ||
Current month | +6.15% | ||
1 month | +8.66% | ||
3 months | -26.60% | ||
6 months | -26.60% | ||
Current year | -5.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Yan Yuemei
CTO | Chief Tech/Sci/R&D Officer | - | - |
Handan He
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Jiong Gu
BRD | Director/Board Member | 51 | 18-03-31 |
Chief Operating Officer | 50 | 19-03-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.78% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1.38 | +2.22% | 3 105 000 |
24-05-17 | 1.35 | -2.88% | 1,646,000 |
24-05-16 | 1.39 | 0.00% | 1,778,000 |
24-05-14 | 1.39 | -2.80% | 728,000 |
24-05-13 | 1.43 | +0.70% | 439,000 |
Delayed Quote Hong Kong S.E., May 20, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.48% | 175M | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+60.20% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+4.57% | 8.79B |
- Stock Market
- Equities
- 1672 Stock